Characteristics |
ATPIII hard coronary heart disease (FRSCHD) |
Cardiovascular diseases generally (FRSCVD) |
High-risk algorithm |
Original (PCE) |
Revised (RPCE) |
Year of development |
2002 |
2008 |
2003 |
2013 |
2018 |
Age group for which applicable (years) |
30–75 |
30–75 |
40–65 |
40–79 |
40–79 |
Populations for which was validated |
Predominantly individuals of Western European descent living in United States of America |
European countries with high CVD risk (e.g.: Hungary) |
Multiethnic cohorts living in United States of America |
Parameters included |
Age, gender, total cholesterol, HDL-cholesterol, systolic blood pressure, BP treatment, and smoking status |
Age, gender, total cholesterol, HDL-cholesterol, systolic blood pressure, BP treatment, diabetes, and smoking status |
Age, gender, total cholesterol, HDL-cholesterol, systolic blood pressure, smoking status |
Age, gender, race, total cholesterol, HDL-cholesterol, systolic blood pressure, BP treatment, diabetes, and smoking status |
Parameters excluded |
Diabetes status, family history of CVD |
Family history of CVD |
BP treatment, diabetes status, family history of CVD |
Family history of CVD |
Endpoints |
CHD death and nonfatal MI |
CHD death, nonfatal myocardial infarction, coronary insufficiency or angina, fatal or nonfatal stroke, and heart failure |
Fatal atherosclerotic CVD events (including CHD, arrhythmia, heart failure, stroke, aortic aneurysm, and peripheral vascular disease) |
CHD death, nonfatal MI, fatal stroke, nonfatal stroke |